View Older Stories View More Recent Stories

Nov 12, 2024 09:38AM Form SC 13G HERON THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A Rezolute, Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A Amalgamated Financial Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A Guild Holdings Co Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A Werewolf Therapeutics, Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:38AM Form SC 13G/A Savara Inc Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A Verastem, Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A Vinci Partners Investmen Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A Aura Biosciences, Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A VERU INC. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A Nkarta, Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:37AM Form SC 13G/A Praxis Precision Medicin Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:36AM Form SC 13G enGene Holdings Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:36AM Form SC 13G IMMUNIC, INC. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:36AM Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:36AM Form SC 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G UroGen Pharma Ltd. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G Lexeo Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G/A Molecular Templates, Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G Aligos Therapeutics, Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G/A KalVista Pharmaceuticals Filed by: Adage Capital Management, L.P.
Nov 12, 2024 09:35AM Form SC 13G TENAX THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
Nov 4, 2024 04:26PM Form SC 13D GLYCOMIMETICS INC Filed by: Adage Capital Management, L.P.
Oct 22, 2024 04:15PM Form SC 13D/A Oruka Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Sep 30, 2024 11:02AM Great Gulf announces minority investment in new ownership group behind purchase of Killington Resort and Pico Mountain
Sep 25, 2024 04:22PM SEC Levies More Than $3.8 Million in Penalties in Sweep of Late Beneficial Ownership and Insider Transaction Reports
Sep 25, 2024 04:20PM Alphabet, Goldman Sachs and others to settle charges over late filings, SEC says
Sep 3, 2024 10:32AM Form N-PX Adage Capital Management For: Jun 30
Aug 30, 2024 09:54AM Form N-PX ADAGE CAPITAL PARTNERS For: Jun 30
Aug 15, 2024 10:11AM Adage Capital’s $10 Million Gift Launches UNCF’s Project ACCLAIM to Accelerate HBCU Student Pathways into Financial Services
Aug 14, 2024 09:39AM Form 13F-NT Adage Capital Management For: Jun 30
Aug 14, 2024 09:38AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
Jul 1, 2024 07:01AM Benitec Biopharma (BNTC) Announces Appointment of Kishen Mehta to its Board of Directors
Jul 1, 2024 07:00AM Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors
Jun 14, 2024 08:04AM Disc Medicine (IRON) Announces 4.94M Share Offering at $36/sh
Jun 14, 2024 08:03AM Disc Medicine Announces Underwritten Offering of Common Stock
Jun 3, 2024 04:30PM Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: Adage Capital Management, L.P.
May 15, 2024 10:49AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Mar 31
May 15, 2024 10:49AM Form 13F-NT Adage Capital Management For: Mar 31
May 13, 2024 08:15AM Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
May 9, 2024 04:05PM Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 9, 2024 07:30AM Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 8, 2024 04:16PM Form 4 ABEONA THERAPEUTICS INC. For: May 07 Filed by: Adage Capital Management, L.P.
May 8, 2024 06:30AM Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 3, 2024 07:30AM Abeona Therapeutics (ABEO) Prices 12.29M Share and Warrant Offering at $4.07/sh
May 3, 2024 07:30AM Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 1, 2024 05:09PM Form SC 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Apr 30, 2024 08:53PM Form SC 13G EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Apr 22, 2024 04:16PM Form 3 EyePoint Pharmaceuticals For: Apr 18 Filed by: Adage Capital Management, L.P.
View More Recent Stories View Older Stories